非裔美国男性前列腺癌外显子组测序揭示ERF功能缺失突变
研究对非裔美国男性局限性初治前列腺癌进行外显子组测序(n=102)和靶向验证(n=90),发现5%病例存在ERF反复功能缺失突变,现有队列中原发前列腺癌ERF缺失占3%、致死性去势抵抗性前列腺癌ERF突变或缺失占3%至5%,敲低ERF可增强非锚定依赖生长并产生致癌ETS激活相关表达特征,提示ERF为前列腺癌抑癌基因。
要点
- 非裔美国男性前列腺癌外显子组测序发现5%病例携带ERF反复功能缺失突变。
- 现有队列中原发前列腺癌ERF缺失占3%,致死性去势抵抗性前列腺癌ERF突变或缺失占3%至5%。
- 敲低ERF增强非锚定依赖生长并产生致癌ETS激活和雄激素信号相关表达特征。
核心结论
- 结果提示ERF是前列腺癌抑癌基因。
- 研究支持在更广泛祖先多样性背景下应用系统性癌症基因组特征分析以促进发现并最终推动治疗应用。
研究设计与样本
- 对非裔美国男性局限性初治前列腺癌进行外显子组测序(n=102)和靶向验证(n=90)。
- 分析现有前列腺癌队列中ERF改变情况。
主要发现
- 外显子组测序和靶向验证发现若干此前未在该背景下观察到的基因突变,包括5%病例中ERF(ETS转录抑制因子)反复功能缺失突变。
- 现有前列腺癌队列分析显示原发前列腺癌中ERF缺失占3%,致死性去势抵抗性前列腺癌中ERF突变或缺失占3%至5%。
- 敲低ERF可增强非锚定依赖生长,并产生与致癌ETS激活和雄激素信号相关的基因表达特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
African-American men have the highest incidence of and mortality from prostate cancer. Whether a biological basis exists for this disparity remains unclear. Exome sequencing (n = 102) and targeted validation (n = 90) of localized primary hormone-naïve prostate cancer in African-American men identified several gene mutations not previously observed in this context, including recurrent loss-of-function mutations in ERF, an ETS transcriptional repressor, in 5% of cases. Analysis of existing prostate cancer cohorts revealed ERF deletions in 3% of primary prostate cancers and mutations or deletions in ERF in 3% to 5% of lethal castration-resistant prostate cancers. Knockdown of ERF confers increased anchorage-independent growth and generates a gene expression signature associated with oncogenic ETS activation and androgen signaling. Together, these results suggest that ERF is a prostate cancer tumor-suppressor gene. More generally, our findings support the application of systematic cancer genomic characterization in settings of broader ancestral diversity to enhance discovery and, eventually, therapeutic applications.Significance: Systematic genomic sequencing of prostate cancer in African-American men revealed new insights into prostate cancer, including the identification of ERF as a prostate cancer gene; somatic copy-number alteration differences; and uncommon PIK3CA and PTEN alterations. This study highlights the importance of inclusion of underrepresented minorities in cancer sequencing studies. Cancer Discov; 7(9); 973-83. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 920.
引用
- Huang FW, Mosquera JM, Garofalo A, et al. Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. Cancer Discov. 2017. PMID: 28515055. doi:10.1158/2159-8290.CD-16-0960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。